Digital cytometry of leukocyte landscapes reveals shared correlates of rejection across organ transplants
Journal of Clinical Investigation · 16.11.2026 · 136 (22)
DOI: 10.1172/jci208686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 22.09.2026. Verfasst von Patrick T Gauthier und 5 weiteren Autor:innen. Beteiligte Einrichtung: Alberta Transplant Applied Genomics Centre, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Graft Rejection, Leukocytes, Organ Transplantation, T-Lymphocytes, Regulatory. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genome Canada, Natera.
Abstract (Originalsprache)
BACKGROUND Improved understanding of the cellular mechanisms of organ transplant rejection is needed for developing targeted therapies to improve outcomes. We used digital cytometry to estimate the digital leukocyte entities (DLE) shared by rejection in biopsies of kidney, heart, lung, and liver organ transplants. METHODS We used CIBERSORTx with the LM22 leukocyte reference to estimate associations between 22 DLEs with rejection in 8,422 transplant biopsies — 4,898 kidney, 2,361 heart, 652 lung, and 538 liver. RESULTS In all organs, rejection correlated with an increase in DLEs designated as classically activated macrophages and a decrease in DLEs designated as regulatory T cells. T cell–mediated rejection (TCMR) was associated with a massive increase in otherwise rare T cell DLEs designated as memory-activated CD4 and Tγδ, as well as follicular-helper CD4 and CD8. TCMR also had increased DLE-designated plasma cells, compatible with a role for the B cell lineage in antigen presentation in TCMR. Antibody-mediated rejection (ABMR) in kidney and heart transplant biopsies correlated with increased DLEs representing activated mast cells, activated NK cells, and monocytes. Some findings were validated by single-cell/nucleus RNA-seq data from kidney and liver biopsies. CONCLUSION The shared correlations of DLEs with rejection in all organs — e.g., CD4ma with TCMR and activated mast cells with ABMR — suggest novel aspects of rejection. These findings can guide the search for the in vivo leukocytes that correspond with the digital entities, with potential clinical applications. TRIAL REGISTRATION ClinicalTrials.gov NCT01299168, NCT02670408, NCT02812290, NCT03193151. FUNDING Genome Canada; Natera Inc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Alberta Transplant Applied Genomics Centre, Edmonton, Alberta, Canada.
- Transcriptome Sciences Inc., Edmonton, Alberta, Canada.
- Department of Medicine V, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
- Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
- University of Alberta, Edmonton, Alberta, Canada.
Förderung
- Genome Canada
- Natera
Zitieren
APA
Gauthier, P. T., Gerhardt, L. M., Jahn, L., Hinze, C., Halloran, P. F., & INTERCOMEX, INTERHEART, INTERLUNG, and INTERLIVER investigators (2026). Digital cytometry of leukocyte landscapes reveals shared correlates of rejection across organ transplants. Journal of Clinical Investigation, 136(22). https://doi.org/10.1172/jci208686
Vancouver
Gauthier PT, Gerhardt LM, Jahn L, Hinze C, Halloran PF, INTERCOMEX, INTERHEART, INTERLUNG, and INTERLIVER investigators. Digital cytometry of leukocyte landscapes reveals shared correlates of rejection across organ transplants. Journal of Clinical Investigation. 2026;136(22). doi:10.1172/jci208686
BibTeX
@article{Gauthier2026,
author = {Gauthier, Patrick T and Gerhardt, Louisa Ms and Jahn, Lorenz and Hinze, Christian and Halloran, Philip F and INTERCOMEX, INTERHEART, INTERLUNG, and INTERLIVER investigators, INTERCOMEX, INTERHEART, INTERLUNG, and INTERLIVER investigators},
title = {Digital cytometry of leukocyte landscapes reveals shared correlates of rejection across organ transplants},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {22},
doi = {10.1172/jci208686}
}
EUVIMED